News

CDC Updates Vaccine Recommendations for Meningococcal, RSV, and Chikungunya
The Centers for Disease Control and Prevention (CDC) has recently updated its vaccine recommendations for three critical diseases: meningococcal, respiratory syncytial virus (RSV), and chikungunya.
Pharmabiz8h
ACIP votes to expand recommendation for Pfizer’s RSV vaccine Abrysvo to include adults aged 50 to 59 at increased risk of disease
the prevention of LRTD caused by RSV in people 18 through 59 years of age who are at increased risk for LRTD caused by RSV pregnant individuals at 32 through 36 weeks gestational age for the ...
Pharmabiz9h
US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59
US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59: London, UK Saturday, April 19, 2025, 09:00 Hrs [IST] GSK ...
Healthbeat on MSN16h
Winter respiratory illnesses winding down in Georgia, but some Covid and flu still circulating
As spring temperatures rise along with pollen counts in Georgia, the state is seeing a decline in winter respiratory ...
Clinical Advisor20h
Vaccine Panel Urges More Protection Against RSV, Meningitis, and Chikungunya
The Advisory Committee on Immunization Practices convened to make expanded vaccine recommendations amidst CDC leadership changes.
Medical Dialogues21h
OSA Patients Face Double the Risk of RSV Infection and Severe Complications: Study Finds
Taiwan: Patients with obstructive sleep apnea (OSA) may face a significantly increased risk of contracting respiratory ...